These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26361060)

  • 1. Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury.
    McAllister TW; Zafonte R; Jain S; Flashman LA; George MS; Grant GA; He F; Lohr JB; Andaluz N; Summerall L; Paulus MP; Raman R; Stein MB
    Neuropsychopharmacology; 2016 Apr; 41(5):1191-8. PubMed ID: 26361060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.
    McDonald BC; Flashman LA; Arciniegas DB; Ferguson RJ; Xing L; Harezlak J; Sprehn GC; Hammond FM; Maerlender AC; Kruck CL; Gillock KL; Frey K; Wall RN; Saykin AJ; McAllister TW
    Neuropsychopharmacology; 2017 Aug; 42(9):1766-1775. PubMed ID: 27874023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial.
    Theadom A; Barker-Collo S; Jones KM; Parmar P; Bhattacharjee R; Feigin VL
    Eur J Neurol; 2018 Aug; 25(8):1055-e82. PubMed ID: 29611892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of methylphenidate for the treatment of mental sequelae after traumatic brain injury.
    Zhang WT; Wang YF
    Medicine (Baltimore); 2017 Jun; 96(25):e6960. PubMed ID: 28640076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study.
    Dymowski AR; Ponsford JL; Owens JA; Olver JH; Ponsford M; Willmott C
    Clin Rehabil; 2017 Jun; 31(6):733-741. PubMed ID: 27353245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzogenol for cognitive functioning in traumatic brain injury: a pilot placebo-controlled RCT.
    Theadom A; Mahon S; Barker-Collo S; McPherson K; Rush E; Vandal AC; Feigin VL
    Eur J Neurol; 2013 Aug; 20(8):1135-44. PubMed ID: 23384428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot trial of memantine in the treatment of posttraumatic stress disorder.
    Battista MA; Hierholzer R; Khouzam HR; Barlow A; O'Toole S
    Psychiatry; 2007; 70(2):167-74. PubMed ID: 17661541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
    Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE
    Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate-mediated motor control network enhancement in patients with traumatic brain injury.
    Dorer CL; Manktelow AE; Allanson J; Sahakian BJ; Pickard JD; Bateman A; Menon DK; Stamatakis EA
    Brain Inj; 2018; 32(8):1040-1049. PubMed ID: 29738277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging.
    Jenkins PO; De Simoni S; Bourke NJ; Fleminger J; Scott G; Towey DJ; Svensson W; Khan S; Patel MC; Greenwood R; Friedland D; Hampshire A; Cole JH; Sharp DJ
    Brain; 2019 Aug; 142(8):2367-2379. PubMed ID: 31199462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis.
    Huang CH; Huang CC; Sun CK; Lin GH; Hou WH
    Curr Neuropharmacol; 2016; 14(3):272-81. PubMed ID: 26951094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of subjective cognitive complaints with neuropsychological tests in individuals with mild vs more severe traumatic brain injuries.
    Jamora CW; Young A; Ruff RM
    Brain Inj; 2012; 26(1):36-47. PubMed ID: 22149443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with methylphenidate for fatigue after traumatic brain injury.
    Johansson B; Wentzel AP; Andréll P; Rönnbäck L; Mannheimer C
    Acta Neurol Scand; 2017 Jan; 135(1):100-107. PubMed ID: 26991608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacologic intervention after hemorrhagic basal ganglia damage.
    Al Owesie RM; Morton CS
    J Neurol Sci; 2012 Nov; 322(1-2):77-8. PubMed ID: 22795553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized pilot trial of topiramate for alcohol use disorder in veterans with traumatic brain injury: Effects on alcohol use, cognition, and post-concussive symptoms.
    Pennington DL; Bielenberg J; Lasher B; Herbst E; Abrams G; Novakovic-Agopian T; Batki SL
    Drug Alcohol Depend; 2020 Sep; 214():108149. PubMed ID: 32712569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term efficacy and tolerability of methylphenidate in children with traumatic brain injury and attention problems.
    Ekinci O; Direk MÇ; Gunes S; Teke H; Ekinci N; Yıldırım F; Okuyaz Ç
    Brain Dev; 2017 Apr; 39(4):327-336. PubMed ID: 27903419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW; Lee JG; Lee BJ; Kim YH
    Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
    Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
    Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.